Clinical Response
Showing 26 - 50 of >10,000
Synovial and Adipose Tissue Composition in Overweight/Obese
Active, not recruiting
- Rheumatoid Arthritis
- Assessment of synovial- and adipose tissue-derived inflammatory biomarkers
-
Rome, ItalyDivision of Rheumatology
Mar 2, 2023
REsponse to Depression Interventions Using Clinical and TD-fNIRS
Enrolling by invitation
- Depression
- Major Depressive Disorder
- fNIRS measurement
-
La Jolla, California
- +2 more
Aug 17, 2023
Rheumatoid Arthritis Trial in Saint-Étienne (Blood sample, CRQ)
Recruiting
- Rheumatoid Arthritis
- Blood sample
- CRQ
-
Saint-Étienne, FranceChu Saint Etienne
Feb 15, 2022
Glycemic Response Trial in Toronto (Commercial native starch without processing, Modified starch with extrusion processing)
Not yet recruiting
- Glycemic Response
- Commercial native starch without processing
- Modified starch with extrusion processing
-
Toronto, Ontario, CanadaINQUIS Clinical Research Ltd.
Sep 15, 2023
Ulcerative Colitis, Crohn's Disease Trial (Vedolizumab IV, Vedolizumab SC)
Not yet recruiting
- Ulcerative Colitis
- Crohn's Disease
- Vedolizumab IV
- Vedolizumab SC
- (no location specified)
Oct 17, 2023
To Evaluate PSQ as Clinical Tool in the Decision Between Medical and Surgical Treatment for Adenotonsillar Hypertrophy, To
Recruiting
- To Evaluate PSQ as Clinical Tool in the Decision Between Medical and Surgical Treatment for Adenotonsillar Hypertrophy
- To Determine Clinical Response to Montelukast or Nasal Steroids Based on PSQ Results
- Montelukast
- Fluticasone Furoate
-
Be'er Ya'aqov, IsraelAssaf-Harofeh Medical Center
Dec 7, 2022
Sepsis, Vitamin B6, Kidney Injury Trial in Huzhou (vitamin B6, 0.9% sodium chloride solution)
Completed
- Sepsis
- +4 more
- vitamin B6
- 0.9% sodium chloride solution
-
Huzhou, Zhejiang, ChinaWen-Ming Feng
Aug 15, 2023
Cancer Patients Treated With Anti-VEGF-Related Therapies
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Electronic Health Record Review
-
Houston, TexasM D Anderson Cancer Center
Oct 25, 2021
Computation Prediction of Drug Response Based on Omics Data
Enrolling by invitation
- Breast Cancer
- virtual anti-cancer drug
-
Beijing, Beijing, ChinaShuhua Zhao
Apr 25, 2023
Metastatic Non-Small Cell Lung Carcinoma Trial in Seoul (Pembrolizumab Injection)
Recruiting
- Metastatic Non-Small Cell Lung Carcinoma
- Pembrolizumab Injection
-
Seoul, Korea, Republic ofSamsung Medical Center
Nov 6, 2022
Ulcerative Colitis Trial (Intravenous (IV) infusions)
Not yet recruiting
- Ulcerative Colitis
- Intravenous (IV) infusions
- (no location specified)
Mar 14, 2023
PD-1 Checkpoint Blockade Using Deep Learning Analysis of Imaging
Completed
- Non-small Cell Lung Cancer (NSCLC)
-
Nîmes, FranceJean-Paul BEREGI
Jan 25, 2023
Periodontal Diseases Trial in Baghdad (test, conventional)
Active, not recruiting
- Periodontal Diseases
- test
- conventional
-
Baghdad, IraqMohammed Kalid Ayoob
Apr 16, 2023
Non-celiac Wheat Sensitivity Trial in Sciacca, Palermo (Wheat flour, Placebo)
Recruiting
- Non-celiac Wheat Sensitivity
- Wheat flour
- Placebo
-
Sciacca, Agrigento, Italy
- +1 more
May 17, 2022
Inflammatory Breast Cancer Trial (Breast conserving surgery, Radical modified mastectomy)
Not yet recruiting
- Inflammatory Breast Cancer
- Breast conserving surgery
- Radical modified mastectomy
- (no location specified)
Nov 14, 2023
Healthy Trial in Nai Muang (Functional beverages from the submerged fermentation of Cordyceps militaris, Fruit juice)
Completed
- Healthy
- Functional beverages from the submerged fermentation of Cordyceps militaris
- Fruit juice
-
Nai Muang, Phayao, ThailandUniversity Of Phayao
Nov 13, 2023
Immune Response Trial in Oxford (Keyhole-Limpet Hemocyanin, Saline, Montanide ISA 51 VG)
Recruiting
- Immune Response
- Keyhole-Limpet Hemocyanin
- +3 more
-
Oxford, United KingdomNIHR Oxford Experimental Medicine Clinical Research Facility
May 16, 2023
Clinical Pre-hospital "Red- Flag" Alert for Activation of
Not yet recruiting
- Trauma Injury
- (no location specified)
Apr 6, 2023
Cervix Uteri Cancer Trial in Tehran (Hypofractionated EBRT, Standard EBRT)
Recruiting
- Cervix Uteri Cancer
- Hypofractionated EBRT
- Standard EBRT
-
Tehran, Iran, Islamic Republic ofImam Khomeini Hospital Complex
Oct 11, 2021
Healthy Nutrition Trial (Food)
Not yet recruiting
- Healthy Nutrition
- Food
- (no location specified)
May 30, 2023
Solid Tumor Trial (LM103)
Not yet recruiting
- Solid Tumor
- LM103
- (no location specified)
Jul 25, 2023
Acute Pancreatitis, Systemic Inflammatory Response Syndrome Trial in Hangzhou (Indometacin, conventional treatment)
Not yet recruiting
- Acute Pancreatitis
- Systemic Inflammatory Response Syndrome
- Indometacin
- conventional treatment
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital, School of Medicine, Zhejiang Univers
Nov 24, 2022
Poor Ovarian Response Trial in Beijing (Jiajian Guishen granules, coenzyme Q10)
Not yet recruiting
- Poor Ovarian Response
- Jiajian Guishen granules
- coenzyme Q10
-
Beijing, Beijing, China
- +1 more
Oct 18, 2023
Cyanotic Heart Disease, Cardiopulmonary Bypass Trial in Karachi (Methylprednisolone, Saline)
Recruiting
- Cyanotic Heart Disease
- Cardiopulmonary Bypass
-
Karachi, Sindh, PakistanAga Khan University Hospital
Jun 30, 2023